Home

Glenmark Pharmaceuticals Ltd Quarterly Result

Image

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

Net Profit - Last Quarter

₹ 348.03 Cr.

Last updated on: Apr 07, 2025

Glenmark Pharmaceuticals Ltd Quarterly Results Key Highlights

  • The revenue of Glenmark Pharmaceuticals Ltd for the Dec '24 is ₹ 3418 crore as compare to the Sep '24 revenue of ₹ 3473 crore.
  • This represent the decline of -1.57%a1# The ebitda of Glenmark Pharmaceuticals Ltd for the Dec '24 is ₹ 631.36 crore as compare to the Sep '24 ebitda of ₹ 641.33 crore.
  • This represent the decline of -1.55%a1# The net profit of Glenmark Pharmaceuticals Ltd for the Dec '24 is ₹ 348.03 crore as compare to the Sep '24 net profit of ₹ 354.49 crore.
  • This represent the decline of -1.82%a1#.

Glenmark Pharmaceuticals Ltd Quarterly Results Analysis

Market Price of Glenmark Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
04 Apr 20251499.15
03 Apr 20251542.9
02 Apr 20251516.3
01 Apr 20251508.75
28 Mar 20251540.05
27 Mar 20251520.75
26 Mar 20251464.1
25 Mar 20251480.2
24 Mar 20251493.1
21 Mar 20251511.45

Historical Revenue of Glenmark Pharmaceuticals Ltd

Created with Highcharts 11.4.83.4k3.5k3.3k3.9k2.7k3.3k3.1kGLENMARKDec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23

* All values are in ₹ crore

Historical EBITDA of Glenmark Pharmaceuticals Ltd

Created with Highcharts 11.4.8631641620855-121257405GLENMARKDec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23

* All values are in ₹ crore

Historical Net Profit of Glenmark Pharmaceuticals Ltd

Created with Highcharts 11.4.8348354340-1.2k-331-62173GLENMARKDec '24Sep '24Jun '24Mar '24Dec '23Sep '23Jun '23

* All values are in ₹ crore

Glenmark Pharmaceuticals Ltd News Hub

Glenmark Pharmaceuticals Ltd spurts 2.5%, rises for fifth straight session

Glenmark Pharmaceuticals Ltd gained for a fifth straight session today. The stock is quoting at Rs 1

Read more

21 Aug 24

Glenmark Pharmaceuticals Ltd soars 4.33%, rises for third straight session

Glenmark Pharmaceuticals Ltd rose for a third straight session today. The stock is quoting at Rs 163

Read more

19 Aug 24

Glenmark Pharma gains after American subsidiary launches Olopatadine generic

The solution is the generic version of 'Pataday Twice Daily Relief', which is distributed by Alcon L

Read more

19 Aug 24

Glenmark launches Olopatadine Hydrochloride Ophthalmic Solution

Glenmark Therapeutics Inc., USA (Glenmark) has launched Olopatadine Hydrochloride Ophthalmic Solutio

Read more

19 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

June 2024

TranscriptPPT

May 2024

PPT

Sep 2023

PPT

Feb 2022

PPT

Nov 2021

PPT

Aug 2021

PPT

May 2021

PPT

FAQs for Quarterly Results of Glenmark Pharmaceuticals Ltd

What key financial metrics are included in Glenmark Pharmaceuticals Ltd's quarterly results?

Key financial metrics in Glenmark Pharmaceuticals Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Glenmark Pharmaceuticals Ltd announce its quarterly results?

Glenmark Pharmaceuticals Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Glenmark Pharmaceuticals Ltd's quarterly performance impact its stock price?

Glenmark Pharmaceuticals Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Glenmark Pharmaceuticals Ltd's quarterly results on dividends?

The impact of Glenmark Pharmaceuticals Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Glenmark Pharmaceuticals Ltd's quarterly results?

Yes, Glenmark Pharmaceuticals Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions